Insider Profile
Eyre, Sally Louise
3
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Jun 30, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Jun 30, 2026 $ELD
Eldorado Gold Corporation
Comp. Grant Buy 473 60
Jun 16, 2026 $ELD
Eldorado Gold Corporation
Plan / DRIP Buy 4 60
Dec 10, 2025 $ERO
Ero Copper
Comp. Grant Buy 2,433 $34.58 $84K 59
Dec 10, 2025 $ERO
Ero Copper
Comp. Grant Buy 3,524 59
Nov 27, 2025 $ERO
Ero Copper
Exercise Sell 4,047 $20.73 59
Nov 27, 2025 $ERO
Ero Copper
Exercise Buy 4,047 $20.73 $84K 59
Mar 31, 2025 $ERO
Ero Copper
Comp. Grant Buy 940 59
Dec 31, 2024 $ERO
Ero Copper
Comp. Grant Buy 933 59
Dec 11, 2024 $ERO
Ero Copper
Comp. Grant Buy 6,016 59
Dec 11, 2024 $ERO
Ero Copper
Comp. Grant Buy 4,047 $20.73 $84K 59
May 31, 2024 $ERO
Ero Copper
Open Market Buy 10,580 59
May 31, 2024 $ERO
Ero Copper
Exercise Buy 6,208 $23.42 $145K 59
May 31, 2024 $ERO
Ero Copper
Exercise Sell 4,372 $18.04 $79K 59
May 31, 2024 $ERO
Ero Copper
Exercise Sell 6,208 $23.42 $145K 59
May 31, 2024 $ERO
Ero Copper
Exercise Buy 4,372 $18.04 $79K 59
Apr 01, 2024 $EQX
Equinox Gold
Other Buy 2,102 $7.64 $16K 70
Feb 06, 2024 $EQX
Equinox Gold
Comp. Grant Buy 17,011 $5.97 $102K 70
Jan 02, 2024 $EQX
Equinox Gold
Other Buy 2,217 $6.69 $15K 70
Dec 29, 2023 $ERO
Ero Copper
Comp. Grant Buy 754 59
Dec 13, 2023 $ERO
Ero Copper
Comp. Grant Buy 6,633 59
Dec 13, 2023 $ERO
Ero Copper
Comp. Grant Buy 4,372 $18.04 $79K 59
Oct 02, 2023 $EQX
Equinox Gold
Other Buy 2,666 $5.71 $15K 70
Sep 29, 2023 $ERO
Ero Copper
Comp. Grant Buy 727 59
Aug 11, 2023 $ERO
Ero Copper
Open Market Buy 8,177 59
Aug 11, 2023 $ERO
Ero Copper
Exercise Sell 4,040 $18.21 $74K 59
Aug 11, 2023 $ERO
Ero Copper
Exercise Sell 4,137 $18.69 $77K 59
Aug 11, 2023 $ERO
Ero Copper
Exercise Buy 4,040 $18.21 $74K 59
Aug 11, 2023 $ERO
Ero Copper
Exercise Buy 4,137 $18.69 $77K 59
Jul 04, 2023 $EQX
Equinox Gold
Other Buy 2,491 $5.97 $15K 70
Jun 30, 2023 $ERO
Ero Copper
Comp. Grant Buy 618 59
Apr 03, 2023 $EQX
Equinox Gold
Other Buy 2,189 $6.95 $15K 70
Mar 31, 2023 $ERO
Ero Copper
Comp. Grant Buy 705 59
Jan 20, 2023 $EQX
Equinox Gold
Exercise Buy 4,733 70
Jan 20, 2023 $EQX
Equinox Gold
Exercise Sell 4,733 70
Jan 16, 2023 $EQX
Equinox Gold
Exercise Buy 3,147 70
Jan 16, 2023 $EQX
Equinox Gold
Exercise Sell 3,147 70
Jan 12, 2023 $EQX
Equinox Gold
Comp. Grant Buy 17,285 70
Jan 03, 2023 $EQX
Equinox Gold
Other Buy 3,137 70
Dec 31, 2022 $ERO
Ero Copper
Comp. Grant Buy 835 59
Oct 31, 2022 $EQX
Equinox Gold
Exercise Sell 585 70
Oct 31, 2022 $EQX
Equinox Gold
Open Market Buy 315 $4.58 $1K 70
Oct 31, 2022 $EQX
Equinox Gold
Exercise Buy 585 $4.62 $3K 70
Oct 03, 2022 $EQX
Equinox Gold
Other Buy 3,208 $4.60 $15K 70
Sep 30, 2022 $ERO
Ero Copper
Comp. Grant Buy 1,125 59
Jun 30, 2022 $ERO
Ero Copper
Comp. Grant Buy 1,265 59
Mar 31, 2022 $ERO
Ero Copper
Comp. Grant Buy 799 59
Jan 20, 2022 $EQX
Equinox Gold
Comp. Grant Buy 9,466 70
Jan 19, 2022 $EQX
Equinox Gold
Open Market Buy 1,578 $9.16 $14K 70
Jan 15, 2022 $EQX
Equinox Gold
Exercise Buy 3,147 70
Jan 15, 2022 $EQX
Equinox Gold
Exercise Sell 3,147 70
Jan 04, 2022 $EQX
Equinox Gold
Other Buy 1,422 70
Dec 31, 2021 $ERO
Ero Copper
Comp. Grant Buy 582 59
Apr 07, 2021 $EQX
Equinox Gold
Corp. Event Sell 2,000 70
Apr 07, 2021 $EQX
Equinox Gold
Corp. Event Buy 2,000 $10.00 $20K 70
Dec 31, 2020 $ERO
Ero Copper
Comp. Grant Buy 553 59
Dec 17, 2020 $ERO
Ero Copper
Comp. Grant Buy 4,677 59
Dec 17, 2020 $ERO
Ero Copper
Comp. Grant Buy 3,601 $18.90 $68K 59
Oct 31, 2020 $EQX
Equinox Gold
Comp. Grant Buy 1,170 70
Sep 30, 2020 $ERO
Ero Copper
Comp. Grant Buy 636 59
Jan 02, 2020 $ERO
Ero Copper
Comp. Grant Buy 6,208 $23.42 $145K 59
Jan 02, 2020 $ERO
Ero Copper
Comp. Grant Buy 3,382 59
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.